EPO and acquired polycythemia vera: JAK2 exon 12 mutation is present in approximately 3% of PV cases and correlates with variable leukocytosis [49] and lower platelet count than JAK2V617F mutated cases but with higher Hb level and a subnormal serum EPO concentration.